Biotechnology Startup Funding

Rejuvenate Bio

Location: -

Funding: Closes $6 M

Date: 15 days ago

Rejuvenate Bio is a biotechnology company developing gene therapies to extend healthy lifespan and treat age-related diseases in companion animals, leveraging advanced regenerative biology techniques through partnerships such as with Merck Animal Health.

Moderna

Location: -

Funding: Raised to $34.00

Date: 18 days ago

Moderna is a biotechnology company specializing in messenger RNA (mRNA) therapeutics and vaccines, developing prophylactic and therapeutic products across infectious diseases, oncology, and rare diseases.

Apogee Therapeutics Inc.

Location: Boston, Massachusetts, United States

Website: apogeetx.com

Funding: Secures Up to $1.3

Date: 21 days ago

Apogee Therapeutics Inc. is a Boston-based clinical-stage biotechnology company focused on developing and commercializing novel immunology therapies, including its lead candidate zumilokibart for the treatment of inflammatory diseases.

POP Biotechnologies, Inc.

Location: Buffalo, NY, USA

Website: pop.bio

Funding: Secures Up to $9.7 M

Date: 22 days ago

POP Biotechnologies, Inc. is a Buffalo-based biotech company developing next-generation vaccines and therapeutics using proprietary porphyrin-phospholipid liposome (SNAP) nanoparticle technology, with its lead vaccine platform advancing toward Phase 1 clinical trials.

Toregem BioPharma

Location: Kyoto, Japan

Funding: raises $5.3 m

Date: 27 days ago

Toregem BioPharma is a Kyoto-based biotechnology company developing TRG035, an experimental tooth-regeneration drug that targets a protein suppressing tooth growth to stimulate dormant tooth buds, initially aiming to treat congenital tooth agenesis with potential applications for age- or injury-related tooth loss.

Apogee Therapeutics

Location: San Francisco, California

Website: apogeetherapeutics.com

Funding: secures $1.3bn

Date: 29 days ago

Apogee Therapeutics is a clinical-stage biotechnology company developing zumilokibart, a novel anti-IL-13 antibody for moderate-to-severe atopic dermatitis, aiming to improve patient outcomes through targeted immunotherapy.

Vera Therapeutics

Location: -

Funding: Closes Out Entire $18.1 M

Date: 31 days ago

Vera Therapeutics is a clinical-stage biotechnology company developing integrin-targeted small molecule therapies for the treatment of autoimmune and inflammatory diseases.

Phytolon Ltd.

Location: Yokne’am, Israel

Website: phytolon.com

Funding: Closes $23.6 M

Date: 31 days ago

Phytolon Ltd. develops and commercializes high-quality natural food colorants using proprietary fermentation technology, offering FDA-approved products like Beetroot Red to food and beverage manufacturers worldwide.

Nanoviricides

Location: -

Website: nanoviricides.com

Funding: raise $2M

Date: 42 days ago

Nanoviricides is a clinical-stage biopharmaceutical company developing biodegradable polymer-based nanomedicines designed to selectively bind and neutralize viruses, aiming to deliver targeted antiviral therapies.

Isomorphic Labs

Location: London, UK

Funding: raises $2.1 Billion

Date: 44 days ago

Isomorphic Labs is a London-based biotech company using artificial intelligence to design novel drugs, accelerating the drug discovery process and reducing research and development timelines.

Isomorphic

Location: -

Funding: raises $2.1 billion

Date: 45 days ago

Isomorphic is a biotechnology company leveraging artificial intelligence to accelerate and scale the drug discovery process, aiming to streamline the development of novel therapeutics.

Isomorphic Labs

Location: London, United Kingdom

Website: isomorphiclabs.com

Funding: secures $2.1 Billion

Date: 45 days ago

Isomorphic Labs is an AI-first drug design and development company that leverages its proprietary artificial intelligence engine to accelerate the discovery and progression of novel therapeutic candidates globally.

Kanvas Biosciences

Location: Princeton, New Jersey, USA

Website: kanvasbio.com

Funding: Raises $48M

Date: 50 days ago

Kanvas Biosciences is a Princeton-based biotech company developing a spatial biology platform to analyze the microbiome and advance immuno-oncology therapies, currently launching clinical trials for its lead candidate, KAN-001.

Citius Oncology

Location: -

Funding: raises $36.5m

Date: 51 days ago

Citius Oncology is an oncology-focused biotechnology company developing and commercializing Lymphir (denileukin diftitox-cxdl), a recombinant fusion protein immune therapy designed to treat lymphoma.

Citius Oncology, Inc.

Location: Cranford, New Jersey

Funding: Secures Up to $36.5 M

Date: 51 days ago

Citius Oncology, Inc. is a clinical-stage biotechnology company focused on developing and commercializing innovative oncology therapies to improve outcomes for cancer patients.

Pacific Hybreed

Location: Big Island, Hawaii

Website: pacifichybreed.com

Funding: Closes $1 M

Date: 52 days ago

Pacific Hybreed is a Big Island-based aquaculture biotechnology company specializing in commercial-scale hatchery production of hybrid shellfish seed to support sustainable shellfish farming and meet growing demand from farmers in Hawaiʻi, the West Coast and beyond.

Lightcast

Location: -

Website: lightcast.bio

Funding: Raises $27M

Date: 72 days ago

Lightcast develops and commercializes functional single-cell analysis technologies that enable deep profiling of individual cell behavior beyond simple identification, empowering researchers and biotech companies to advance discoveries in drug development and life sciences research.

Percheron Therapeutics

Location: -

Funding: raises $2.2 m

Date: 73 days ago

Percheron Therapeutics is a clinical-stage biotechnology company developing novel therapeutics, currently advancing its lead candidate HMBd-002 into Phase II clinical trials following a A$2.2 million equity raise.

Annovis Bio, Inc.

Location: Malvern, Pennsylvania

Website: annovisbio.com

Funding: Closes $10 M

Date: 77 days ago

Annovis Bio, Inc. is a Phase 3 clinical-stage biotechnology company developing buntanetap, an investigational oral therapy for neurodegenerative diseases including Alzheimer’s and Parkinson’s, aiming to slow disease progression and improve patient outcomes.

Assembly Biosciences

Location: -

Funding: Raised to $43.00

Date: 78 days ago

Assembly Biosciences is a clinical-stage biotechnology company developing novel small molecule antivirals targeting chronic hepatitis B and D viruses as well as microbiome-based therapeutics for gastrointestinal diseases.

Aktis Oncology

Location: -

Funding: Raised to $33.00

Date: 84 days ago

Aktis Oncology is a clinical-stage biotechnology company developing targeted small-molecule therapies for cancer, focusing on selective kinase inhibitors to treat hematologic and solid tumor malignancies.

Moderna

Location: Cambridge, Massachusetts, USA

Website: moderna.com

Funding: Raised to $48.00

Date: 85 days ago

Moderna is a biotechnology company specializing in messenger RNA (mRNA) therapeutics and vaccines, leveraging its mRNA platform to rapidly develop novel treatments and preventive vaccines for infectious diseases and other medical conditions.

Semarion

Location: Cambridge, UK

Funding: secures $3.8 m

Date: 87 days ago

Semarion is a University of Cambridge spin-out developing next-generation cell assay technology that combines materials engineering and cell biology to improve drug screening and accelerate pharmaceutical adoption.

Denali Therapeutics

Location: South San Francisco, California, USA

Website: denalitherapeutics.com

Funding: Raised to $40.00

Date: 89 days ago

Denali Therapeutics is a clinical-stage biotechnology company developing therapeutics for neurodegenerative diseases by leveraging a proprietary platform to deliver drugs across the blood-brain barrier.

Sarepta Therapeutics

Location: -

Funding: Raised to $13.00

Date: 89 days ago

Sarepta Therapeutics is a biopharmaceutical company focused on developing precision genetic medicines for rare neuromuscular diseases, aiming to transform patient care through innovative therapies.

EpiFrontier Therapeutics, Inc.

Location: Pennington, NJ, USA

Website: epifrontiertx.com

Funding: Secures up to $32M

Date: 94 days ago

EpiFrontier Therapeutics, Inc. is a biotechnology company developing first-in-class epigenetic therapies for beta globin disorders, including EPF-001, a novel G9a inhibitor targeting sickle cell disease and beta thalassemia.

Stoke Therapeutics

Location: -

Funding: Raised to $40.00

Date: 98 days ago

Stoke Therapeutics is a clinical-stage biotechnology company leveraging RNA-based splicing modulation to develop targeted therapies for rare genetic diseases, aiming to restore normal protein production.

Alto Neuroscience

Location: -

Funding: Raised to $22.00

Date: 98 days ago

Alto Neuroscience is a clinical-stage precision neurology company developing biomarker-driven diagnostics and therapeutics to improve treatment selection and outcomes for central nervous system disorders.

Rubi

Location: -

Funding: raises $7.5m

Date: 100 days ago

Rubi is a Series A startup developing and scaling advanced enzyme platforms and production systems to commercialize sustainable, cost-effective industrial bioproducts with improved efficiency and reduced costs.

Design Therapeutics

Location: -

Funding: Raised to $14.00

Date: 108 days ago

Design Therapeutics is a clinical-stage biotechnology company developing precision gene therapies for rare diseases, leveraging proprietary AAV vector technology to deliver novel genetic medicines.

ACADIA Pharmaceuticals

Location: San Diego, California, USA

Website: acadia.com

Funding: Raised to $35.00

Date: 120 days ago

ACADIA Pharmaceuticals is a biopharmaceutical company that develops and commercializes small molecule therapies for central nervous system disorders, aiming to address unmet medical needs in conditions such as schizophrenia and Parkinson’s disease psychosis.

Vir Biotechnology

Location: -

Funding: Raised to $18.00

Date: 122 days ago

Vir Biotechnology is a clinical-stage immunology company developing innovative therapies, including monoclonal antibodies and immunomodulators, to prevent and treat serious infectious diseases.

Armata Pharmaceuticals

Location: -

Funding: Raised to $15.00

Date: 123 days ago

Armata Pharmaceuticals is a clinical-stage biotechnology company developing bacteriophage-based therapies to treat antibiotic-resistant bacterial infections, offering targeted antimicrobial solutions to address unmet medical needs.

Cizzle Biotechnology

Location: -

Website: cizzlebiotech.com

Funding: secures additional US$3.5 m

Date: 123 days ago

Cizzle Biotechnology is a UK-based clinical-stage biotech company focused on developing and advancing novel therapeutic candidates in oncology and metabolic disorders, leveraging proof-of-concept-driven asset acquisition and royalty financing to support its US product launches.

Amylyx Pharmaceuticals

Location: -

Funding: Raised to $19.00

Date: 123 days ago

Amylyx Pharmaceuticals is a biopharmaceutical company developing novel small-molecule therapies for neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), with a focus on slowing disease progression and improving patient outcomes.

Prothena

Location: Dublin, Ireland

Website: prothena.com

Funding: Raised to $12.00

Date: 125 days ago

Prothena is a clinical-stage biotechnology company that discovers and develops protein-targeted therapeutics for immunology and neuroscience disorders.

Resverlogix Corp.

Location: Calgary, Alberta, Canada

Website: resverlogix.com

Funding: Closes $2.8 M

Date: 127 days ago

Resverlogix Corp. is a Calgary-based, publicly traded biotechnology company focused on developing epigenetic therapies for chronic diseases by leveraging small-molecule inhibitors to modulate gene activity.

Genmab A/S

Location: Copenhagen, Denmark

Website: genmab.com

Funding: Raised to $40.00

Date: 128 days ago

Genmab A/S is a biotechnology company specializing in the development and commercialization of innovative antibody therapeutics for the treatment of cancer and other serious diseases.

Aerska

Location: Dublin, Ireland

Website: aerska.com

Funding: raises $39M

Date: 135 days ago

Aerska is a Dublin-based biotech company developing proprietary delivery platforms to transport RNA-based therapeutics across the blood-brain barrier, enabling the development of treatments for neurodegenerative diseases.

Aerska

Location: Dublin, Ireland

Funding: raises $39m

Date: 136 days ago

Aerska is a Dublin-based biotech firm developing RNA interference (RNAi) therapeutics designed to reach the brain and switch off harmful genes linked to neurological diseases such as Alzheimer’s.

Aerska

Location: Ireland

Funding: raises $39M

Date: 136 days ago

Aerska develops brain shuttle technology to deliver RNAi therapeutics across the blood-brain barrier, enabling targeted treatment of neurological disorders.

CytomX Therapeutics

Location: -

Funding: Raised to $10.00

Date: 139 days ago

CytomX Therapeutics is a clinical-stage biotechnology company developing conditionally activated antibody therapies (Probody therapeutics) to selectively target cancer cells while minimizing off-target toxicity, with the goal of delivering safer and more effective cancer treatments.

Tyra Biosciences

Location: -

Funding: Raised to $43.00

Date: 143 days ago

Tyra Biosciences is a clinical-stage biopharmaceutical company developing precision oncology small molecule therapies that target key cancer cell cycle pathways to improve patient outcomes.

Cantai Therapeutics

Location: University City, Philadelphia, PA, USA

Funding: raises $3M

Date: 147 days ago

Cantai Therapeutics is a virtual-model biotechnology startup headquartered in Philadelphia’s University City that develops novel therapeutic solutions, leveraging partnerships and digital infrastructure to streamline drug discovery and development.

Mustgrow Biologics

Location: Vancouver, Canada

Funding: closes $2M

Date: 154 days ago

Mustgrow Biologics is an agricultural biotechnology company that develops peptide-based biopesticides using synthetic biology to enhance crop protection and sustainability.

Definium Therapeutics

Location: -

Funding: Raised to $36.00

Date: 154 days ago

Definium Therapeutics is a biopharmaceutical company developing epigenetic therapies by targeting histone modifications to regulate gene expression and treat cancer and other diseases.

COMPASS Pathways

Location: -

Funding: Raised to $21.00

Date: 154 days ago

COMPASS Pathways is a clinical-stage biotechnology company developing psilocybin-based therapies for treatment-resistant depression, aiming to transform patient care through innovative psychedelic-assisted treatments.

Zelira Therapeutics

Location: Brisbane, Australia

Website: zeliratx.com

Funding: secures transformative US$33 m

Date: 161 days ago

Zelira Therapeutics is an Australian clinical-stage biotechnology company developing evidence-based cannabinoid therapies for neurological and mental health conditions such as autism, leveraging rigorous clinical research and non-dilutive funding like its US$33 million HOPE 1 Autism Program to advance safe and effective treatment options.

Vyriad

Location: Rochester, Minnesota

Website: vyriad.com

Funding: raises additional $25M

Date: 163 days ago

Vyriad is a biotechnology company developing genetically engineered viral therapies that selectively target cancer cells to deliver therapeutic genetic payloads, aiming to enhance precision and efficacy in cancer treatment.

Axol Bioscience Ltd.

Location: Edinburgh, UK

Funding: raises $2.8 M

Date: 163 days ago

Axol Bioscience Ltd is a biotechnology company specializing in induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research.

Converge Bio

Location: Boston, MA & Tel Aviv, Israel

Website: converge-bio.com

Funding: raises $25M

Date: 164 days ago

Converge Bio is a biotech startup leveraging artificial intelligence to accelerate drug discovery, aiming to shorten R&D timelines and improve the success rate of novel therapeutics.

Avenue Biosciences

Location: Palo Alto, USA and Helsinki, Finland

Funding: raises $5.7 m

Date: 165 days ago

Avenue Biosciences develops a scalable protein manufacturing platform to efficiently produce high-quality proteins for research and therapeutic applications.

Monte Rosa Therapeutics

Location: -

Funding: Raised to $30.00

Date: 166 days ago

Monte Rosa Therapeutics is a biotechnology company leveraging computational and experimental platforms to discover and develop novel allosteric small-molecule modulators targeting G protein-coupled receptors for diseases with high unmet medical needs.

Boltz

Location: -

Funding: secures $28m

Date: 168 days ago

Boltz develops open-source AI foundation models for biomolecular research, partnering with major pharmaceutical firms like Pfizer to accelerate drug discovery by analyzing and generating biological data.

Monte Rosa Therapeutics

Location: -

Funding: Raised to $34.00

Date: 169 days ago

Monte Rosa Therapeutics is a genomics-driven biotechnology company that leverages advanced computational and machine-learning platforms to design targeted immunotherapies for cancer and other diseases, accelerating drug discovery and development.

Sana Biotechnology

Location: -

Funding: Raised to $7.00

Date: 171 days ago

Sana Biotechnology is a biotechnology company developing engineered cells and gene therapies for treating diseases. The company uses gene-editing and cell-engineering techniques to restore or enhance cellular function in patients.

KalVista Pharmaceuticals

Location: -

Funding: Raised to $32.00

Date: 171 days ago

KalVista Pharmaceuticals is a biopharmaceutical company focused on discovering and developing small molecule protease inhibitors for the treatment of protease‐mediated diseases, including hereditary angioedema, with the goal of advancing novel therapeutic candidates through clinical development.

10x Genomics

Location: -

Funding: Raised to $20.00

Date: 183 days ago

10x Genomics develops advanced single-cell and spatial genomics analysis platforms that enable high-resolution cellular and molecular profiling to accelerate research in biology and medicine.

Nawah Scientific

Location: Egypt

Funding: raises $23 m

Date: 190 days ago

Nawah Scientific offers a cloud-based laboratory platform enabling researchers to remotely access and automate life-science experiments, accelerating research workflows and scaling scientific innovation.

DBV Technologies

Location: -

Funding: Raised to $45.00

Date: 191 days ago

DBV Technologies is a clinical-stage biotechnology company developing innovative allergy immunotherapies using its proprietary Viaskin epicutaneous patch technology to deliver allergens through intact skin and promote immune tolerance.

Alphyn Biologics

Location: Cincinnati, Ohio

Funding: lands $25M

Date: 196 days ago

Alphyn Biologics is a Cincinnati-based biotechnology firm developing novel topical biologic therapies for dermatological conditions such as eczema and molluscum contagiosum.

Racura

Location: Perth, Australia

Funding: secures $3.2M

Date: 196 days ago

Racura is a clinical-stage oncology biotechnology company developing innovative treatments for lung cancer, currently funded by a A$3.2M grant to support its clinical trial.

Allarity Therapeutics

Location: -

Funding: Raised to $9.50

Date: 196 days ago

Allarity Therapeutics is a clinical-stage biotechnology company developing personalized cancer therapies by integrating diagnostic biomarkers to select patients most likely to benefit from its treatments.

Nuvation Bio

Location: -

Funding: Raised to $18.00

Date: 197 days ago

Nuvation Bio is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel targeted therapies for cancer and rare diseases.

Locus Fermentation Solutions

Location: Solon, Ohio, USA

Website: locusfs.com

Funding: Secures $40 M

Date: 198 days ago

Locus Fermentation Solutions is a U.S.-based industrial biotechnology company that uses proprietary fermentation processes to produce performance-enhancing, bio-based intermediates. Its sustainable additive solutions serve oil & gas, mining, agriculture, industrial, and consumer packaged goods markets.

Nurix Therapeutics

Location: San Diego, California

Website: nurix.com

Funding: Raised to $30.00

Date: 198 days ago

Nurix Therapeutics is a clinical-stage biotechnology company discovering and developing small molecule therapeutics that modulate protein homeostasis to treat cancer and immune-inflammatory diseases.

EpilepsyGTx

Location: UK

Funding: raises $33 m

Date: 198 days ago

EpilepsyGTx is a UK-based biotechnology company developing single-dose gene therapies for focal refractory epilepsy, advancing its lead candidate EPY201 into Phase 1/2a clinical trials to provide durable treatment options for patients with drug-resistant seizures.

Senti Biosciences

Location: -

Funding: Raised to $13.00

Date: 199 days ago

Senti Biosciences is a clinical-stage synthetic biology company that engineers programmable gene circuits to develop targeted cell therapies for treating complex diseases.

IGC Pharma

Location: -

Funding: Raised to $4.75

Date: 199 days ago

IGC Pharma is a clinical-stage biopharmaceutical company developing immune cell therapies to treat autoimmune diseases and prevent transplant rejection through regulatory cell modulation.

Convergen

Location: -

Funding: Secures $10 M

Date: 200 days ago

Convergen is a biotech startup developing its proprietary TRIMTAC platform to create targeted therapeutics for neurodegenerative diseases and beyond.

Axoltis Pharma

Location: -

Website: axoltis.com

Funding: secures $18m

Date: 200 days ago

Axoltis Pharma is a biotechnology company developing novel therapeutics for neurodegenerative diseases. The company recently raised $18 million in Series A funding to advance its pipeline targeting conditions such as Alzheimer’s and Parkinson’s disease.

Pan Cancer T

Location: Rotterdam, Netherlands

Funding: raises $11.6m

Date: 200 days ago

Pan Cancer T is a Rotterdam-based biotechnology company developing TCR-T cell therapies for cancer, currently advancing its lead candidate PCT1:CO-Stim into clinical trials for triple-negative breast cancer.

Arcus Biosciences

Location: -

Funding: Raised to $26.00

Date: 207 days ago

Arcus Biosciences is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies that target immune checkpoints to enhance anti-tumor responses. Its pipeline includes small molecules and biologics aimed at improving the efficacy and safety of cancer treatments.

Ruminant Biotech

Location: Auckland, New Zealand

Funding: raises $17m

Date: 212 days ago

Ruminant Biotech is a New Zealand agri-biotech company developing an oral methane-reducing pill for ruminant livestock, aiming to slash greenhouse gas emissions and support more sustainable farming.

Ruminant Biotech

Location: Auckland, New Zealand

Funding: raises $17m

Date: 213 days ago

Ruminant Biotech develops a methane-reducing feed additive pill for cattle and other ruminants, helping farmers slash greenhouse gas emissions. The Auckland-based startup is gearing for a trans-Tasman launch with a manufacturing facility capable of producing one million doses per year.

CRISPRBits

Location: Hyderabad, India

Funding: raises $3 M

Date: 213 days ago

CRISPRBits is a Hyderabad-based biotech startup specializing in CRISPR gene editing technologies, providing advanced gene editing tools to accelerate research and therapeutic development.

Moderna

Location: Cambridge, Massachusetts, USA

Website: modernatx.com

Funding: Secures $1.5

Date: 213 days ago

Moderna is a biotechnology company specializing in messenger RNA (mRNA) therapeutics and vaccines, leveraging its proprietary platform to develop and manufacture treatments for infectious diseases, immuno-oncology, rare diseases, and cardiovascular conditions.

Olema Pharmaceuticals

Location: -

Funding: Raised to $26.00

Date: 217 days ago

Olema Pharmaceuticals is a clinical-stage biotechnology company focused on developing novel therapies for inflammatory and dermatological diseases, including psoriasis and atopic dermatitis.

Scholar Rock

Location: -

Funding: Raised to $45.00

Date: 221 days ago

Scholar Rock is a clinical-stage biopharmaceutical company developing targeted protein therapeutics that modulate the TGF-β superfamily to treat serious muscular and fibrotic diseases.

Cidara Therapeutics

Location: -

Funding: Secures $9.2 Billion

Date: 223 days ago

Cidara Therapeutics is a clinical-stage biotechnology company developing novel long-acting anti-infective and immunomodulatory therapies to treat and prevent serious infectious diseases.

Regeneron Pharmaceuticals

Location: Saratoga Springs, New York, USA

Website: regeneron.com

Funding: lands $2 billion

Date: 224 days ago

Regeneron Pharmaceuticals is a biotechnology company that discovers, develops, and manufactures innovative biologic therapies for serious diseases. Leveraging proprietary technology platforms, it accelerates drug discovery and scales production to bring transformative treatments to market.

CereCura Nanotherapeutics

Location: Vancouver, Canada

Website: cerecura.com

Funding: secures $1.4 m

Date: 224 days ago

CereCura Nanotherapeutics is a UBC spinout developing nanotherapeutic platforms based on COVID-19 vaccine technology to deliver therapeutic proteins across the blood-brain barrier, targeting neurological disorders like Alzheimer’s and Parkinson’s.

Terns Pharmaceuticals

Location: -

Funding: Raised to $33.00

Date: 225 days ago

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for metabolic and immune-mediated diseases, including treatments for non-alcoholic steatohepatitis (NASH).

Nanoviricides

Location: -

Funding: closes $6M

Date: 225 days ago

Nanoviricides is a nanomedicine biotechnology company developing targeted antiviral therapies using proprietary nanomicelle technology to treat a broad range of viral infections.

RAGE Biotech

Location: Melbourne, Australia

Funding: Lands $29M

Date: 225 days ago

RAGE Biotech is a Melbourne-based biotech spinout from Monash University developing precision RNA-based therapeutics using splice-switching oligonucleotides and RAGE biology to treat chronic inflammatory diseases, with the goal of advancing these novel therapies into clinical use.

RAGE Biotech

Location: Melbourne, Australia

Funding: raises $29 m

Date: 225 days ago

Melbourne-based RAGE Biotech develops novel therapies for chronic lung disease and has raised $29 million in Series A funding to advance its lead treatment into first-in-human clinical trials.

NurExone Biologic Inc.

Location: Toronto, Canada and Haifa, Israel

Website: nurexone.com

Funding: Secures over C$3.18 M

Date: 226 days ago

NurExone Biologic Inc. is a clinical-stage biotechnology company that develops extracellular matrix-based therapeutics and medical devices for tissue regeneration, enabling innovative solutions in wound healing and reconstructive medicine.

enGene

Location: -

Funding: Raised to $19.00

Date: 226 days ago

enGene is a clinical-stage biotechnology company developing targeted oral gene therapies using engineered bacterial vectors to deliver therapeutic genes to the gastrointestinal tract, aiming to treat diseases such as ulcerative colitis and gastrointestinal cancers.

Modulight Biotherapeutics

Location: United States

Funding: secures $12m

Date: 226 days ago

Modulight Biotherapeutics is a U.S.-based biotechnology startup developing optogenetic therapies that precisely target neurons to treat neurological disorders.

Adaptive Biotechnologies

Location: -

Funding: Raised to $16.00

Date: 227 days ago

Adaptive Biotechnologies is a biotechnology company leveraging its proprietary immune medicine platform to decode the adaptive immune system and develop diagnostic tools and therapies across a range of diseases.

Nanoviricides

Location: Shelton, Connecticut, USA

Website: nanoviricides.com

Funding: raises $6M

Date: 227 days ago

Nanoviricides develops nanotechnology-based antiviral therapeutics that mimic the body’s immune mechanisms to specifically target and neutralize viruses, aiming to provide effective treatments for a broad range of viral infections.

Metsera

Location: -

Funding: secures $10 billion

Date: 227 days ago

Metsera is a biotechnology company developing novel obesity drugs currently in clinical stages, aiming to address the growing global obesity market with innovative therapeutic solutions.

BioHarvest Sciences

Location: -

Funding: raises $19.9M

Date: 227 days ago

BioHarvest Sciences is a biotechnology company that uses proprietary plant cell fermentation technology to produce consistent, high-quality botanical ingredients without soil or pesticides, serving the health, wellness and pharmaceutical markets.

Relay Therapeutics

Location: -

Funding: Raised to $6.00

Date: 228 days ago

Relay Therapeutics is a biotechnology company that leverages computational modeling and protein motion analysis to discover and develop novel small-molecule therapies targeting various diseases.

Prothena

Location: -

Funding: Raised to $30.00

Date: 228 days ago

Prothena is a clinical-stage biotechnology company focused on discovering and developing novel therapies for neurodegenerative and systemic amyloid diseases.

Maze Therapeutics

Location: -

Funding: Raised to $36.00

Date: 228 days ago

Maze Therapeutics is a clinical-stage biotechnology company that leverages human genetics and functional genomics to discover and develop novel therapies for cardiometabolic and other diseases.

Zymeworks

Location: -

Funding: Raised to $17.00

Date: 228 days ago

Zymeworks is a clinical-stage biotechnology company that leverages its proprietary protein engineering platform to develop next-generation antibody-based therapeutics targeting oncology and immunology indications.

Metsera

Location: -

Funding: Secures $10 Billion

Date: 228 days ago

Metsera is a biotechnology startup specializing in the development of weight-loss treatments.

Metsera

Location: New York, USA

Funding: Secures $10 Billion

Date: 229 days ago

Metsera is a New York–based biotechnology company developing novel obesity drugs, offering innovative therapies for the rapidly expanding weight-loss market.

Prothena

Location: -

Funding: Raised to $11.00

Date: 230 days ago

Prothena is a clinical-stage biotechnology company developing antibody-based therapies targeting protein dysregulation in neuroscience, immunology and oncology, with a focus on amyloidosis and related neurodegenerative disorders.

NewAmsterdam Pharma

Location: -

Funding: Raised to $44.00

Date: 230 days ago

NewAmsterdam Pharma is a clinical-stage biopharmaceutical company developing therapies that enhance nitric oxide availability to treat metabolic and cardiovascular diseases.

Exelixis

Location: -

Funding: Raised to $40.00

Date: 230 days ago

Exelixis is an oncology-focused biopharmaceutical company that discovers, develops, and commercializes small molecule therapies to treat cancer.

Dianthus Therapeutics

Location: -

Funding: Raised to $46.00

Date: 230 days ago

Dianthus Therapeutics is a clinical-stage biotechnology company developing targeted protein degradation therapies to treat cancer and immune diseases, leveraging a proprietary platform to discover and optimize novel molecular degraders.

Onchilles Pharma

Location: -

Website: onchillespharma.com

Funding: Raises $25M

Date: 231 days ago

Onchilles Pharma is a biotech company pioneering next-generation cytotoxic cancer therapies by advancing its lead candidate N17350 and other ELANE-pathway programs to improve treatment efficacy and safety.

Adicet Bio

Location: -

Funding: Raised to $9.00

Date: 231 days ago

Adicet Bio is a clinical-stage biotechnology company developing off-the-shelf gamma delta T cell therapies to treat cancer and other diseases. The company's proprietary allogeneic platform enables scalable, cost-effective cell therapy solutions with enhanced safety and efficacy.

BioHarvest Sciences

Location: Israel

Funding: raise $17.4M

Date: 231 days ago

BioHarvest Sciences is an Israeli biotechnology company leveraging plant cell-fermentation technology to produce high-purity active ingredients for cosmetics, nutraceuticals, and pharmaceutical markets.

Adaptive Biotechnologies

Location: -

Funding: Raised to $20.00

Date: 232 days ago

Adaptive Biotechnologies uses proprietary immune repertoire sequencing to develop diagnostics and therapeutics, enabling precise disease detection and monitoring by mapping the adaptive immune response.

Amicus Therapeutics

Location: -

Funding: Raised to $11.00

Date: 233 days ago

Amicus Therapeutics is a biopharmaceutical company specializing in developing treatments for rare genetic diseases, using enzyme replacement and small molecule therapies to address underlying disease mechanisms.

Rigel Pharmaceuticals

Location: -

Funding: Raised to $38.00

Date: 233 days ago

Rigel Pharmaceuticals is a biopharmaceutical company developing novel small molecule therapies for inflammatory diseases, immune disorders, and cancer.

Rigel Pharmaceuticals

Location: -

Funding: Raised to $38.00

Date: 233 days ago

Rigel Pharmaceuticals is a biotechnology company specializing in the discovery, development, and commercialization of small molecule therapies for immunologic, hematologic, and oncologic diseases.

SylamoreBio

Location: Jonesboro, Arkansas

Funding: secure $3M

Date: 239 days ago

SylamoreBio is a biotechnology company based at Arkansas State University in Jonesboro, Arkansas, focused on developing innovative biotherapeutics and advancing life-saving research through federally funded NIH SBIR programs.

Evaxion A/S

Location: Copenhagen, Denmark

Funding: raises $7.2 m

Date: 239 days ago

Evaxion A/S is a Copenhagen-based clinical-stage biotechnology company that leverages artificial intelligence and machine learning to discover and develop novel immunotherapies and vaccines, accelerating drug discovery and clinical development.

Kyverna Therapeutics

Location: -

Funding: Raised to $20.00

Date: 239 days ago

Kyverna Therapeutics is a clinical-stage biotechnology company developing CRISPR-based gene editing and allogeneic cell therapies targeting genetic blood disorders and immuno-oncology, aiming to provide off-the-shelf engineered T-cell treatments for diseases such as sickle cell disease and cancer.

Pinetree Therapeutics

Location: Cambridge, MA

Website: pinetreetx.com

Funding: Raises $47 M

Date: 240 days ago

Pinetree Therapeutics is a preclinical-stage biotechnology company developing targeted protein degraders for drug-resistant cancers, leveraging its proprietary AbReptor™ platform to advance lead oncology programs into clinical development.

Cellcolabs

Location: Sweden

Website: cellcolabs.com

Funding: secures $12 m

Date: 242 days ago

Cellcolabs is a Swedish biotech startup specializing in scalable stem cell manufacturing platforms, enabling efficient and cost-effective production of therapeutic-grade cells for drug development and cell therapy applications.

ENA Respiratory

Location: Melbourne, Australia

Funding: raises $34 m

Date: 242 days ago

ENA Respiratory is a Melbourne-based biotech company developing INNA-051, a virus-agnostic nasal spray designed to prevent and treat respiratory viral infections by enhancing mucosal immune response.

Generation Lab

Location: -

Funding: raises $11 m

Date: 246 days ago

Generation Lab is a longevity-focused biotechnology startup that harnesses personalized health data from wearables, devices, and tests to develop interventions aimed at extending healthy human lifespan.

ENA Respiratory

Location: Melbourne, Australia

Website: enarespiratory.com

Funding: secures US$22.4m

Date: 247 days ago

ENA Respiratory is a Melbourne-based biotechnology company developing nasal spray therapies to prevent viral respiratory infections. Its lead candidate, INNA-051, is a once-weekly dry powder nasal spray currently advancing into phase 2 clinical trials.

Kaleira Therapeutics

Location: Waltham, Massachusetts

Website: kailera.com

Funding: raised $1

Date: 248 days ago

Kaleira Therapeutics is a growth-stage biotechnology company developing novel therapeutic candidates to address serious diseases and unmet medical needs through advanced research and development.

Orthocell

Location: Sydney, Australia

Website: orthocell.com

Funding: secures A$30 m

Date: 252 days ago

Orthocell is an Australian clinical-stage regenerative medicine company developing and commercializing collagen-based biomaterial products for tissue repair and aesthetic applications, including its lead dermal filler Remplir and bone repair scaffold CelGro.

Mission Therapeutics

Location: Cambridge, UK

Website: missiontherapeutics.com

Funding: raises $13.3 m

Date: 254 days ago

Mission Therapeutics is a clinical-stage biotechnology company based in Cambridge, UK, developing first-in-class, potentially disease-modifying therapies for Parkinson’s disease, with its lead candidate MTX325 entering Phase Ib clinical trials.

Bexorg, Inc.

Location: New Haven, Connecticut, USA

Website: bexorg.com

Funding: Raises $42.5M

Date: 254 days ago

Bexorg, Inc. operates an AI-driven, whole human brain platform to accelerate and improve predictive discovery and development of central nervous system drugs.

InBio

Location: -

Funding: Secures $3.5 M

Date: 255 days ago

InBio is a global biotechnology company specializing in allergy research and development of innovative immunotherapeutic tools targeting common allergens from house dust mites, cats, and dogs to advance treatments for allergic reactions and asthma.

Emergent BioSolutions Inc.

Location: Gaithersburg, Maryland, USA

Website: emergentbiosolutions.com

Funding: Secures $29 M

Date: 280 days ago

Emergent BioSolutions is a biotechnology company that develops, manufactures, and supplies medical countermeasures—including vaccines, therapeutics, and devices—to protect against infectious diseases, chemical, and radiological threats for government and public health partners.

Clearmind Medicine Inc.

Location: Vancouver, Canada

Website: clearmindmedicine.com

Funding: Secures $10 m

Date: 280 days ago

Clearmind Medicine Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel psychedelic-derived therapeutics to address major under-treated health problems.

Clearmind Medicine Inc.

Location: Vancouver, Canada

Website: clearmindmedicine.com

Funding: Secures $10 m

Date: 280 days ago

Clearmind Medicine Inc. is a Nasdaq-listed clinical-stage biotechnology company focused on discovering and developing novel psychedelic-based therapeutics for mental health disorders.

Medicus Pharma

Location: -

Funding: secures $8M

Date: 281 days ago

Medicus Pharma is a clinical-stage biopharmaceutical company developing novel therapeutics to treat severe respiratory viral infections, with a pipeline of small molecule antivirals targeting RSV, COVID-19, and influenza.

Bio Protocol

Location: Zug, Switzerland

Website: bio.xyz

Funding: Raises $6.9M

Date: 282 days ago

Bio Protocol is a Zug, Switzerland–based decentralized science platform that empowers researchers and patients to deploy autonomous AI co-scientists (“BioAgents”) to generate hypotheses and fund experiments. It enables users to monetize biotech discoveries and accelerate drug discovery outside traditional pharmaceutical models.

OxyLo

Location: Sydney, Australia

Funding: Secures $1.4M

Date: 296 days ago

OxyLo is a University of New South Wales spinout developing HypoxyCaps, a novel hypoxia-responsive platform designed to improve the efficacy of cancer treatments through targeted drug delivery.

Mineralys Therapeutics

Location: -

Funding: Raised to $43.00

Date: 299 days ago

Mineralys Therapeutics is a clinical-stage biotechnology company developing novel small-molecule ion channel modulators to treat cardiometabolic and neuropsychiatric disorders, aiming to deliver precision medicines with improved efficacy and safety.

Imugene

Location: Melbourne, Australia

Website: imugene.com

Funding: raises A$2.42M

Date: 302 days ago

Imugene is a clinical-stage immuno-oncology biotechnology company based in Melbourne, Australia, developing B-cell immunotherapies—such as cancer vaccines and cell therapies—to stimulate targeted anti-tumor immune responses.

Debut

Location: -

Funding: Secures $20M

Date: 303 days ago

Debut is a biotech beauty startup that leverages its AI-driven BeautyORB platform to discover and scale novel skincare ingredients aimed at enhancing skin longevity. It recently secured $20 million in Series A funding to accelerate platform expansion and entry into Asian markets.

Debut

Location: San Diego, California, U.S.

Funding: Secures $20M

Date: 304 days ago

Debut is a San Diego-based biotech startup that leverages an AI-driven ingredient discovery platform to develop and formulate novel skincare solutions aimed at advancing skin longevity, with growing operations in Asian markets.

NF2 BioSolutions

Location: -

Funding: raises nearly $8K

Date: 312 days ago

NF2 BioSolutions is a biotechnology company focused on developing diagnostics and therapies for Neurofibromatosis Type 2, a rare genetic disorder. It supports research and treatment development to improve outcomes for patients affected by this condition.

Gameto

Location: -

Website: gametogen.com

Funding: Secures $44M

Date: 318 days ago

Gameto is a clinical-stage biotechnology company developing stem cell therapies to treat infertility and menopause.

Tryptamine

Location: -

Funding: secures $2.6 m

Date: 318 days ago

Tryptamine is a clinical-stage biotechnology company developing psilocin-based therapeutics for central nervous system disorders, leveraging novel psychedelic compounds to address unmet mental health needs.

Tahoe Therapeutics

Location: Palo Alto, California, U.S.

Funding: Raises $30M

Date: 319 days ago

Tahoe Therapeutics is a Palo Alto-based biotech company that uses its AI-driven Mosaic platform and Tahoe-100M dataset to simulate human cells for cancer drug discovery, aiming to accelerate the development of precision medicine therapies.

Tahoe Therapeutics

Location: -

Website: tahoebio.ai

Funding: Raised $30 M

Date: 319 days ago

Tahoe Therapeutics is a biotechnology startup that uses artificial intelligence to build detailed digital simulations of living cells. Their platform aims to improve the accuracy of drug response predictions, accelerating drug discovery and reducing risks in preclinical testing.

Recce Pharmaceuticals

Location: Australia

Funding: raise $7.4 m

Date: 388 days ago

Recce Pharmaceuticals is a clinical-stage biotechnology company developing novel synthetic antimicrobial peptides to treat multi-drug resistant bacterial infections, providing broad-spectrum therapies designed to overcome antibiotic resistance.

Vivodyne

Location: Philadelphia, PA

Website: vivodyne.com

Funding: raised $40 m

Date: 389 days ago

Vivodyne is a biotechnology company that develops human tissue-based platforms to replace animal testing in drug development, aiming to accelerate drug discovery and reduce related costs.

Kyron.bio

Location: -

Website: kyron.bio

Funding: Secures $6.2M

Date: 392 days ago

Kyron.bio is a biotechnology startup offering precision glycan engineering platforms to optimize and accelerate biologic drug development, enhancing preclinical studies and therapeutic performance.

Vivodyne

Location: South San Francisco, CA

Website: vivodyne.com

Funding: Secures $40M

Date: 392 days ago

Vivodyne develops an AI and robotics-powered platform for human tissue testing, enabling advanced and scalable solutions for biomedical research and drug development.

Phase Scientific

Location: Hong Kong

Website: phasescientific.com

Funding: Raised $34 M

Date: 399 days ago

Phase Scientific is a biotechnology startup specializing in urine-based diagnostic tests to help detect cancer, aiming to improve early diagnosis and patient outcomes.

Mito Robotics

Location: Pittsburgh, PA

Funding: raises $1M

Date: 400 days ago

Mito Robotics develops automated solutions to improve and scale cell growth processes in laboratories, addressing challenges in biomanufacturing for advanced therapies such as exosome treatment and organ transplants.

Imprint

Location: New York City, NY

Website: imprint.bio

Funding: raises $15 m

Date: 402 days ago

Imprint is a biotechnology startup focused on decoding immune memory to advance personalized medicine and immunotherapy. The company originated from Cornell Tech’s Runway program and leverages cutting-edge research to deliver innovative healthcare solutions.

RevolKa Ltd

Location: Sendai, Japan

Website: revolka.com

Funding: Raises US$1.4M

Date: 402 days ago

RevolKa Ltd is a biotechnology company specializing in AI-driven protein engineering through its aiProtein platform, with a focus on advancing drug discovery programs for rare diseases and supporting collaborative partnerships.

PHASE Scientific International Limited

Location: Hong Kong SAR

Website: phasescientific.com

Funding: Raises US$34 M

Date: 402 days ago

PHASE Scientific International Limited develops innovative diagnostic technologies for early detection of diseases, including multiple cancers, women's health issues, and infectious diseases, with a focus on urine-based diagnostics.

ACADIA Pharmaceuticals

Location: -

Funding: Raised to $31.00

Date: 403 days ago

ACADIA Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of therapies for central nervous system disorders, including Parkinson’s disease psychosis.

Armata Pharmaceuticals

Location: -

Website: armatapharma.com

Funding: Raised to $9.00

Date: 403 days ago

Armata Pharmaceuticals is a clinical-stage biotechnology company developing bacteriophage-based and immunotherapeutic solutions to treat serious bacterial infections and combat antibiotic resistance.

Enliven Therapeutics

Location: -

Funding: Raised to $40.00

Date: 405 days ago

Enliven Therapeutics is a clinical-stage biotechnology company developing novel small molecule therapies that modulate epigenetic and immune pathways to treat cancer.

Bovotica

Location: Brisbane, Australia

Funding: raised $11.4 m

Date: 407 days ago

Bovotica is a biotechnology startup developing methane-reducing probiotics for cows, aimed at reducing greenhouse gas emissions in agriculture.

Therini Bio, Inc.

Location: Sacramento, Calif.

Website: therinibio.com

Funding: Raises Additional $39M

Date: 408 days ago

Therini Bio, Inc. is a clinical-stage biotechnology company developing fibrin-targeting immunotherapies aimed at treating neurodegenerative diseases driven by vascular dysfunction, including Alzheimer's disease.

Agenus

Location: -

Funding: Raised to $4.00

Date: 409 days ago

Agenus is a biotechnology company focused on developing immuno-oncology therapies and vaccine adjuvants designed to harness and enhance the immune system’s response against cancer and infectious diseases.

Trailhead Biosystems

Location: Beachwood, OH

Website: trailbio.com

Funding: Raises $20M

Date: 412 days ago

Trailhead Biosystems specializes in human cell innovation, utilizing an informatics-driven approach to develop iPSC-derived cells for applications in regenerative medicine, preclinical drug discovery, and disease modeling.

ImmuneWalk Therapeutics

Location: NYC, USA

Website: immunewalk.com

Funding: Raises $7M

Date: 414 days ago

ImmuneWalk Therapeutics is a clinical-stage biotechnology company developing therapies focused on modulating immune and inflammatory diseases through monocyte inhibition.

Nuevocor

Location: Singapore

Website: nuevocor.com

Funding: Closes US$45 M

Date: 416 days ago

Nuevocor is a biotechnology company developing pioneering mechanobiology-centered therapies, including its lead candidate NVC-001 aimed at treating LMNA-related dilated cardiomyopathy (LMNA DCM). Their innovative approach targets significant unmet medical needs in cardiomyopathy through clinical-trial stage therapies.

Stately Bio

Location: Palo Alto, CA

Website: statelybio.com

Funding: Raises $12M

Date: 420 days ago

Stately Bio develops regenerative medicine therapies using a patented machine learning-powered live-cell imaging platform, notably producing liver cells with significantly enhanced functionality compared to existing technologies.

Amply Discovery

Location: Belfast, Northern Ireland

Funding: raises $1.75m

Date: 421 days ago

Amply Discovery is a biotech firm leveraging a proprietary AI-driven platform to accelerate the discovery of innovative medicines, particularly targeting cancer therapies.

Amply

Location: Belfast, Northern Ireland

Website: amply.bio

Funding: raises $1.75m

Date: 421 days ago

Amply is a biotech firm leveraging its AI-driven drug discovery platform to develop innovative medicines targeting aggressive cancers and drug-resistant pathogens.

Grove Biopharma

Location: Chicago, Illinois

Funding: secures $30 m

Date: 427 days ago

Grove Biopharma is a biotechnology startup founded by Northwestern University researchers, focused on developing new classes of drugs aimed at treating cancer and other diseases.

Araceli Biosciences

Location: Portland, OR

Website: aracelibio.com

Funding: Closes $11.2M

Date: 428 days ago

Araceli Biosciences specializes in high-content imaging and AI-powered analysis, enabling advancements in personalized medicine through innovative hardware and software solutions for real-time biomedical analysis.

Grove Biopharma

Location: Chicago, IL

Website: grovebiopharma.com

Funding: Raises $30M

Date: 428 days ago

Grove Biopharma is a biotechnology company focused on advancing its proprietary platform to develop oncology treatments, aiming to move its lead programs toward clinical trials.

Atossa Therapeutics

Location: -

Funding: Raised to $7.25

Date: 428 days ago

Atossa Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for breast cancer and other breast conditions.

Cytovation ASA

Location: Bergen, Norway

Website: cytovation.com

Funding: Raises US$6m

Date: 429 days ago

Cytovation ASA is a clinical-stage biotechnology company focused on developing novel therapeutics such as CY-101 to treat cancers linked to the dysfunctional Wnt/β-catenin pathway, including adrenocortical carcinoma and colorectal cancer.